A Multi-Center Cohort Study Examining Risk Factors for Central Nervous System Metastases (cnsm) in Patients with Stage III Non-Small Cell Lung Cancer (NSCLC) Treated with Definitive Chemoradiation (chemort) Followed by Durvalumab (Durva).
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined